Park Edge Advisors LLC Sells 440 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Park Edge Advisors LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 31.8% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 944 shares of the healthcare conglomerate’s stock after selling 440 shares during the period. Park Edge Advisors LLC’s holdings in UnitedHealth Group were worth $552,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in UNH. J.W. Cole Advisors Inc. raised its position in shares of UnitedHealth Group by 28.8% during the 3rd quarter. J.W. Cole Advisors Inc. now owns 11,450 shares of the healthcare conglomerate’s stock valued at $6,694,000 after purchasing an additional 2,557 shares during the period. Ellis Investment Partners LLC raised its holdings in UnitedHealth Group by 0.8% during the third quarter. Ellis Investment Partners LLC now owns 3,141 shares of the healthcare conglomerate’s stock valued at $1,836,000 after acquiring an additional 26 shares during the period. State of Alaska Department of Revenue boosted its stake in shares of UnitedHealth Group by 6.4% in the third quarter. State of Alaska Department of Revenue now owns 117,851 shares of the healthcare conglomerate’s stock worth $68,904,000 after acquiring an additional 7,135 shares during the period. Carret Asset Management LLC raised its stake in UnitedHealth Group by 11.3% during the 3rd quarter. Carret Asset Management LLC now owns 7,955 shares of the healthcare conglomerate’s stock valued at $4,651,000 after purchasing an additional 810 shares during the period. Finally, Financial Management Professionals Inc. boosted its stake in UnitedHealth Group by 58.4% in the 3rd quarter. Financial Management Professionals Inc. now owns 2,116 shares of the healthcare conglomerate’s stock worth $1,237,000 after purchasing an additional 780 shares during the period. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of a number of research analyst reports. Argus boosted their target price on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. KeyCorp assumed coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective for the company. Bank of America lowered their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Robert W. Baird upped their price objective on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. Finally, Barclays cut their target price on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. Four research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Stock Up 0.7 %

Shares of NYSE:UNH opened at $564.56 on Monday. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The business’s 50 day moving average is $583.52 and its 200 day moving average is $538.58. The stock has a market cap of $521.33 billion, a P/E ratio of 36.78, a price-to-earnings-growth ratio of 1.66 and a beta of 0.58. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $608.63.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same period in the previous year, the company posted $6.56 earnings per share. The firm’s quarterly revenue was up 9.2% on a year-over-year basis. Sell-side analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.49%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.